News & Events


Recent Firm Activities and Highlights

Health Decisions Appoints Sheila Kiss as Head of European Clinical Operations
03.31.19
Health Decisions, Inc., the full-service clinical research organization (CRO) of choice for forward-looking biopharma and medical device companies and a leader in women’s health and diagnostics studies, has appointed Sheila Kiss as Head of European Clinical Operations. With more than 35 years’ experience in Clinical Operations and Project Management, Kiss will support Health Decisions’ dedicated Clinical Operations Team to execute research in Women’s Health and In Vitro Diagnostic clinical development. Read Full Release
MEDAPTUS NAMES DR. SUSAN KATZ SLISKI AS CHIEF NURSING OFFICER
02.05.19
Susan Katz Sliski, DNP, RN, CCM, FAAOHN has been named the Chief Nursing Officer (CNO) for MedAptus, Inc. In her role, Dr. Katz Sliski will be working closely with the product management team to promote and improve all MedAptus products, with a special focus on ASSIGN for Nurses, the company’s flagship patient assignment software for nurses. In her most recent role prior to joining MedAptus, Dr. Katz Sliski was leading REDESIGN initiatives within healthcare organizations to improve patient and provider experiences, drive organizational effectiveness and decrease costs. Read Full Release
COTA
HIMSS19: The Importance of Data and Managing Expectations
02.01.19
It’s that time of year again! As we get ready for all that HIMSS has to offer and learn about exciting opportunities in healthcare, it’s important to manage expectations around what is going to be accomplished at the conference. It’s no surprise that HIMSS continues to get bigger and bigger every year, but many of the same things are still being discussed - Artificial Intelligence (AI), Machine Learning, Natural Language Processing, data security and improving efficiencies, to name a few. Read Full Release
MedAptus
MEDAPTUS RANKED #1 IN KLAS RANKINGS FOR MOBILE CHARGE CAPTURE IN 2019
01.31.19
“This is one more indication of our commitment towards providing the very best charge management solutions in healthcare,” said Eugene Schneider, MedAptus president and CEO. “Whether it’s for professionals, facilities or even infusion coding services, our charge capture, management and reconciliation processes are consistently finding new sources of revenue for our customers. That’s extremely important as hospitals and other entities continue to tighten belts in this very challenging healthcare environment.” Read Full Release
Reveleer
Boston Millennia Partners Leads Investment in Reveleer, Inc.
01.21.19
Boston Millennia Partners IV is pleased to announce its investment in Reveleer, Inc. as part of a growth equity financing round. Reveleer is a healthcare software and services company that empowers health insurance companies to take control of their risk adjustment and quality improvement programs. The Reveleer software platform enables insurers to independently execute and manage every aspect of provider outreach, health record retrieval, coding, abstraction, and reporting. Leveraging its technology, proprietary data sets, and subject matter expertise, Reveleer also provides record retrieval and review services to support financial performance and improved member outcomes. As value-based contracts expand and the Medicare Advantage population continues to grow, the company is well positioned to be a leader in risk adjustment and quality analysis software. Click below to read on. Read Full Release
To Improve Treatments, Researchers Want To Hunt For Clues In Medical Records
07.15.18
When you go to your doctor's office, sometimes it seems the caregivers spend more time gathering data about you than treating you as a patient. Electronic medical records are everywhere – annoying to doctors and intrusive to patients. But now researchers are looking to see if they can plow through the vast amount of data that's gathered in those records, along with insurance billing information, to tease out the bits that could be useful in refining treatments and identifying new uses for drugs. Read Full Release
COTA
Data sharing company helps improve cancer patient outcomes, reduce total cost of care
07.13.18
Over the years oncologists and health care experts have struggled to find new ways to reduce the cost of cancer treatment. The American Cancer Society estimates patients paid nearly $4 billion in out-of-pocket costs in 2014, and that the disease cost the country around $88 billion in cancer-related health care spending that same year. Some doctors are now looking at emerging oncology data companies to help reduce that financial burden all while improving clinical outcomes. Read Full Release
Health Decisions, Inc.
US CRO Health Decisions and European CRO/SMO Comac Medical Expand Transatlantic Collaboration in Women’s Health
06.27.18
Durham, North Carolina and Sofia, Bulgaria. Health Decisions, Inc., the leading US full-service women’s health specialty CRO and Comac Medical, a full-service CRO/SMO operating in 24 European countries, today announced an expansion of their strategic alliance to conduct women’s health clinical trials in the United States, Western and Central and Eastern Europe. “Health Decisions is pleased to strengthen its strategic women’s health alliance with our colleagues at Comac Medical,” stated Health Decisions’ Chief Executive Officer Patrick Phillips, BSc (Hons), D.Phil. “The Health Decisions/Comac Medical alliance provides sponsors of women’s health trials with extensive therapeutic and operational expertise and access to hundreds of investigational women’s health sites in the United States and Europe. These regions provide care for hundreds of millions of women and generate approximately two-thirds of the revenues of the global biopharmaceutical industry. This strategic alliance will enable Health Decisions to fulfill its mission of improving healthcare outcomes for women worldwide and assisting sponsors who share that goal.” Read Full Release
COTA
Cota Founder and Executive Chairman to Present at the Vatican’s Unite to Cure Conference
04.27.18
Cota Inc., a real-world data and analytics company bridging precision medicine to population health, today announced its founder and executive chairman, Andrew Pecora, M.D., will speak today, April 27 at the Fourth International Vatican Conference, Unite to Cure: A Global Health Care Initiative, which is being held from April 26-28 at the Aula Nuova del Sinodo in Vatican City. The event will build on the current global health care movement and unite world leaders across all disciplines to engage in powerful conversations about how science, technology and 21st century medicine will impact culture and society. Read Full Release
COTA
HIMSS18: Interview with Stuart Goldberg, M.D. | Cota | Precision Payment
03.29.18
On this episode we talk with Stuart Goldberg, MD, Chief Scientific Officer at Cota. Dr. Goldberg tells us all about Cota’s physician-led journey to organize and classify real-world evidence about every type of cancer. This effort led to something they call the Cota Nodal Address (CNA), and it’s enabling health systems to get very specific about the types of patients they’re treating, the costs associated with them, and the outcomes being achieved. This apples-to-apples comparison allows Cota to identify variation and address it in ways that are beneficial to the provider, payer and patient. It enables a concept Dr. Goldberg calls “Precision Payment”, which in turn enables proper bundled payment design, and precision medicine. Read Full Release